Journal article
Musculoskeletal health of subjects with hemophilia A treated with tailored prophylaxis: Canadian Hemophilia Primary Prophylaxis (CHPS) Study
Abstract
BACKGROUND: Full-dose prophylaxis is very effective at minimizing joint damage but is costly. Tailored prophylaxis has been proposed as a way of reducing costs while still protecting joints.
OBJECTIVE: To report detailed findings in index joints of 56 subjects with severe hemophilia A entered into the Canadian Hemophilia Prophylaxis Study, and treated with tailored prophylaxis, after 13 years.
Authors
Hilliard P; Zourikian N; Blanchette V; Chan A; Elliott B; Israels SJ; Nilson J; Poon M-C; Laferriere N; Van Neste C
Journal
Journal of Thrombosis and Haemostasis, Vol. 11, No. 3, pp. 460–466
Publisher
Elsevier
Publication Date
March 2013
DOI
10.1111/jth.12113
ISSN
1538-7933
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Biomechanical PhenomenaCanadaChildChild, PreschoolCoagulantsDisability EvaluationDrug Administration ScheduleFactor VIIIHemarthrosisHemophilia AHumansInfantJointsKaplan-Meier EstimateLinear ModelsMaleMuscular AtrophyPhysical ExaminationRange of Motion, ArticularRecombinant ProteinsSeverity of Illness IndexSurveys and QuestionnairesTime FactorsTreatment Outcome